secwatch / observer
8-K filed June 16, 2022, 7:59 PM ET ticker SON CIK 0000091767
leadership confidence high sentiment neutral materiality 0.60

Sonoco director Micali retires; CFO Albrecht separation agreement details disclosed

SONOCO PRODUCTS CO

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James M. Micali

Director
SON · SONOCO PRODUCTS CO
Effective
2022-06-20
Filed
June 16, 2022, 7:59 PM ET
On June 11, 2022, James M. Micali extended his resignation from the Board of Directors (the “Board of Directors”) of Sonoco Products Company (the “Company”), effective June 20, 2022.
Departed

Julie C. Albrecht

Chief Financial Officer
SON · SONOCO PRODUCTS CO
Effective
2022-06-30
Filed
June 16, 2022, 7:59 PM ET
the Company and Julie C. Albrecht, the Company’s Vice President and Chief Financial Officer, agreed to a separation effective as of June 30, 2022

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

James M. Micali resigned as Director at SONOCO PRODUCTS CO.

Action
resigned
Role
Director
Exact text from the filing
On June 11, 2022, James M. Micali extended his resignation from the Board of Directors (the “Board of Directors”) of Sonoco Products Company (the “Company”), effective June 20, 2022.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Julie C. Albrecht departed as Chief Financial Officer at SONOCO PRODUCTS CO.

Action
separated
Role
Chief Financial Officer
Exact text from the filing
the Company and Julie C. Albrecht, the Company’s Vice President and Chief Financial Officer, agreed to a separation effective as of June 30, 2022
View on SEC.gov

SONOCO PRODUCTS CO filing history →

Source: SEC EDGAR
accession 0001104659-22-071896
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.